Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
566 studies found for:    glioma | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Conditions: Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma;   Brainstem Glioma
Interventions: Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
2 Recruiting Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study
Condition: Glioma
Intervention: Procedure: Detecting of Biological Borders of Gliomas
3 Unknown  Gene Expression, Immunological Status and Metabolome in Glioma Patients
Condition: Glioma
Interventions: Procedure: Glioma resection;   Other: Blood sampling
4 Recruiting Fluorescence and Glioma Heterogeneity
Condition: Malignant Gliomas
Intervention: Procedure: ALA Test group
5 Recruiting Brain Glioma Registry Combining Clinical and Imaging Information
Condition: Adult Glioma
Intervention: Other: Brain Glioma Registry
6 Recruiting A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
Conditions: Newly Diagnosed Pediatric Pontine Glioma.;   Newly Diagnosed Pediatric High Grade Glioma.;   Recurrent Pediatric High Grade Glioma.;   Recurrent Pediatric Low Grade Glioma.
Interventions: Biological: HLA-A2 restricted glioma antigen peptides vaccine;   Biological: Poly-ICLC
7 Recruiting Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
Conditions: Oligodendroglioma;   Astrocytoma, Grade II;   Glioma, Astrocytic;   Glioma;   Malignant Glioma;   Oligoastrocytoma, Mixed
Interventions: Biological: GBM6-AD and poly-ICLC before and after surgery;   Biological: GBM6-AD and poly-ICLC after surgery only
8 Recruiting Case-cohort Study of Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma
Condition: Glioma
Interventions: Drug: Midazolam;   Drug: propofol;   Drug: Dexmedetomidine
9 Not yet recruiting Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
Condition: Recurrent High-grade Glioma
Interventions: Drug: Ultra-low dose Bevacizumab;   Drug: Temozolomide
10 Recruiting 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
Conditions: Glioma;   Breast Cancer
Intervention: Radiation: 68Ga-NOTA-NFB
11 Not yet recruiting A Phase II Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
Condition: Glioma
Interventions: Device: NovoTTF-200A;   Drug: Temozolomide
12 Recruiting Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Conditions: Cholangiocarcinoma;   Chondrosarcoma;   Glioma;   Other Advanced Solid Tumors
Intervention: Drug: AG-120
13 Recruiting Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Conditions: Diffuse Intrinsic Pontine Glioma;   Brainstem Glioma
14 Recruiting iMRI Guided Resection in Cerebral Glioma Surgery
Condition: Glioma
Interventions: Procedure: iMRI;   Procedure: conventional neuronavigation
15 Recruiting Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Conditions: Brain Tumor;   Glioblastoma;   Anaplastic Glioma
Interventions: Drug: everolimus;   Drug: sorafenib
16 Not yet recruiting A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Conditions: Glioma;   Malignant Glioma;   Astrocytoma, Grade II;   Oligodendroglioma;   Glioma, Astrocytic;   Oligoastrocytoma, Mixed
Interventions: Biological: IMA950;   Biological: poly-ICLC;   Biological: Varlilumab
17 Unknown  Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
Conditions: Epilepsy;   Glioma
18 Recruiting Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation
Conditions: Cholangiocarcinoma;   Chondrosarcoma;   Glioma
Intervention: Drug: AG881
19 Recruiting Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas
Conditions: Low Grade Glioma;   Malignant Glioma
20 Recruiting Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   High Grade Glioma
Interventions: Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Leukapheresis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years